Skip to Content

MYLAN 2264 MYLAN 2264 (Terazosin Hydrochloride 2 mg)

Pill with imprint MYLAN 2264 MYLAN 2264 is Black / Purple, Capsule-shape and has been identified as Terazosin Hydrochloride 2 mg. It is supplied by Mylan Pharmaceuticals Inc..

Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 2 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 2264 MYLAN 2264

Terazosin hydrochloride 2 mg MYLAN 2264 MYLAN 2264
Terazosin hydrochloride 2 mg MYLAN 2264 MYLAN 2264 Front
Terazosin hydrochloride 2 mg MYLAN 2264 MYLAN 2264 Back
Terazosin hydrochloride 2 mg MYLAN 2264 MYLAN 2264

Terazosin Hydrochloride

Imprint
MYLAN 2264 MYLAN 2264
Strength
2 mg
Color
Black / Purple
Size
14.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antiadrenergic agents, peripherally acting
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
lactose anhydrous, silicon dioxide, D&C Red No. 28, D&C Red No. 33, FD&C Blue No. 1, magnesium stearate, microcrystalline cellulose, corn starch, sodium lauryl sulfate, titanium dioxide, ferrosoferric oxide, ammonia, propylene glycol, shellac, dimethicone

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00378-2264 Mylan Pharmaceuticals Inc.
51079-0937 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.